肠梗阻导管联合奥曲肽治疗粘连性肠梗阻的疗效观察

摘要
图/表
参考文献
相关文章 (0)

全文: PDF (1422 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的：观察肠梗阻导管联合奥曲肽治疗粘连性肠梗阻的临床疗效。方法：收集78例确诊为粘连性肠梗阻的患者，用随机数字表将患者分为联合组、肠梗阻导管组和奥曲肽组，每组26例，3组均给予常规综合治疗，在此基础上联合组给予肠梗阻导管联合奥曲肽治疗，肠梗阻导管组给予肠梗阻导管治疗，奥曲肽组给予奥曲肽联合鼻胃管减压治疗，观察并比较3组的临床症状和疗效。结果：联合组腹痛缓解时间、恢复排气时间较肠梗阻导管组和奥曲肽组缩短，第1个24 h胃肠减压量较肠梗阻导管组减少，较奥曲肽组增加，差异有统计学意义（P＜0.05或P＜0.01）。联合组患者治疗总有效率（为100%）明显高于肠梗阻导管组（为84.6%）和奥曲肽组（为73.1%），3组比较差异有统计学意义（P＜0.05或P＜0.01）。结论：联合应用肠梗阻导管和奥曲肽能减少胃肠减压量，更快缓解粘连性肠梗阻患者的症状，增加患者治疗总有效率，临床疗效确切。

	服务
	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	赵叶芳
	马良

关键词 ：肠梗阻导管, 奥曲肽, 粘连性肠梗阻, 疗效观察

Abstract：Objective: To observe the curative effect of intestinal obstruction catheter complex combined with octreotide in the treatment of adhesive intestinal obstruction. Methods: A total of 48 adhesive intestinal obstruction patients were collected and randomly divided into the combination group (16 patients), the intestinal obstruction catheter group (16 patients) and the octreotide group (16 patients). Three groups were all treated with the routine comprehensive therapy, while the combination group added intestinal obstruction catheter and octreotide, the intestinal obstruction catheter group added intestinal obstruction catheter and the octreotide group added octreotide and nasogastric tube. Clinical symptoms and curative effect of there groups were observed and compared.The experimental data were analyzed by statistical methods. Results: After therapy, the bloating pain relief time and recovery exhaust time in the combination group were shorter than that in other two groups. The amount of first 24 h gastrointestinal decompression of the combination group was less than the intestinal obstruction catheter group and more than the octreotide group (P<0.05 or P<0.01). While the total effective rate of the combination group (100%) was higher than that of the other two groups (P<0.05 or P<0.01). Conclusion: The intestinal obstruction catheter complex combined octreotide in treatment of adhesive intestinal obstruction can reduce the gastrointestinal decompression amount, relieve the clinical symptoms probiotics in the adhesive intestinal obstruction patients fastly, and increase patient treatment efficiency.

Key words： intestinal obstruction catheter octreotide adhesive intestinal obstruction curative effect observation

收稿日期: 2015-02-16

作者简介: 赵叶芳（1974-），女，浙江绍兴人，主治医师。

链接本文:

https://xb.wmu.edu.cn/CN/ 或 https://xb.wmu.edu.cn/CN/Y2015/V45/I12/911

[1] Timothy BL, Mehul VR, Marleta R, et a1. Adhesive small bowel obstruction in children and adolescents: operative utilization and factorts associated with bowel loss[J]. Journal of the American College of Surgeons, 2011, 212(5):855-861.
[2] Komatsu I, Tokuda Y, Shimada G, et a1. Development of a simple model for predicting need for surgery in patients who initially undergo conservative management for adhesive small bowel obstruction[J]. The American Journal of Surgery, 2010, 200(2): 215-223.
[3] 梁德森, 陈天宇, 孙备, 等. 临床应用甘遂治疗粘连性肠梗阻的疗效观察[J]. 中国中西医结合杂志, 2001, 4(21): 312-313.
[4] 于金海, 孙东辉, 刘国辉, 等. 应用肠梗阻导管治疗老年结核性腹膜炎并发肠梗阻的体会[J]. 中国老年学杂志,2009, 29(21): 2799-2800.
[5] 石美鑫. 实用外科学[M]. 2版. 北京: 人民卫生出版社,2002: 819.
[6] 金殷植, 孙立波, 宋摇, 等. 肠梗阻导管对粘连性肠梗阻的治疗作用[J]. 中华胃肠外科杂志, 2009, 12(6): 580.
[7] 姚芳, 范一宏, 吕宾, 等. 肠梗阻导管在肠梗阻患者过渡治疗中的价值[J]. 浙江临床医学, 2013, 15(5): 657-658.
[8] Gowen GF. Rapid resolution of small bowel obstruction with the long tube, endoscopically advanced into the jejunum[J]. Am J Surg, 2007, 193(1): 184-189.
[9] Ripamonti C, Easson AM, Gerdes H. Management of malignant bowel obstruction[J]. Eur J Cancer, 2008, 44(8): 1105-1115.
[10] 胡文昌, 夏志伟, 刘黎明, 等. 微量泵输入大剂量奥曲肽治疗急性肠梗阻的临床分析[J]. 中国急救医学, 2011, 31(1):67-68.
[11] Jimnez-Garcia A, Balongo-Garcia R, Alconero FF, et a1. Intestinal wall damage in simple ileus in rabbits: immune-modulator role of Soma tostatin[J]. Hepatogastroenterology, 2004, 51(58): 1030-1036.
[12] Kanno Y, Hirasaws D, Fujita N, et a1. Long-tube insertion with the ropeway method facilitated by a guidewire placed by transnasal ultrathin endoscopy for bowel obstruction:a prospective, randomized, controlled tria1[J]. Gastrointest Endosc, 2009, 69(7): 1363-1368.